Fairmount Funds Management LLC 13D and 13G filings for Astria Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 3:45 pm Purchase |
2024-12-31 | 13G | Astria Therapeutics, Inc. ATXS |
Fairmount Funds Management LLC | 5,869,037 9.900% |
992 (+0.02%) |
Filing |
| 2024-11-14 4:15 pm Purchase |
2024-09-30 | 13G | Astria Therapeutics, Inc. ATXS |
Fairmount Funds Management LLC | 5,868,045 9.900% |
2,234,080 (+61.48%) |
Filing |
| 2024-02-14 3:48 pm Purchase |
2023-12-31 | 13G | Astria Therapeutics, Inc. ATXS |
Fairmount Funds Management LLC | 3,633,965 9.900% |
1,732,568 (+91.12%) |
Filing |
| 2023-02-14 3:45 pm Purchase |
2022-12-31 | 13G | Astria Therapeutics, Inc. ATXS |
Fairmount Funds Management LLC | 1,901,397 6.900% |
989,661 (+108.55%) |
Filing |
| 2022-02-08 4:31 pm Sale |
2021-12-31 | 13G | Astria Therapeutics, Inc. ATXS |
Fairmount Funds Management LLC | 911,736 7.000% |
-62,869 (-6.45%) |
Filing |
| 2021-09-22 3:57 pm Purchase |
2021-09-20 | 13G | Astria Therapeutics, Inc. ATXS |
Fairmount Funds Management LLC | 974,605 7.600% |
974,605 (New Position) |
Filing |